For more information about SiVEC visit www.sivecbiotechnologies.com
SiVEC Biotechnologies is an innovative R&D company building a portfolio of therapeutic biological products, including antivirals for the rapid prevention and treatment of diseases. SiVEC Biotechnologies holds expertise and intellectual property (IP) for a platform technology that can be applied to target a wide range of diseases in humans and animals. Efforts are focused on broadening our bacterial platform’s applications, with an emphasis on ensuring strong IP protection.
SiVEC’s current product platforms include: a biological platform for nucleic acid delivery, SiVEC-IAV™ – a biological antiviral for human flu, and SiVEC-AIV™ – a biological antiviral for avian flu.
How an Idea
Became a Company
Founder Lynsey Linke shares her memories on the origin of SiVEC:
“[- content-.”
CSU-Affiliated Founders
How founding SiVEC changed my career goals
“- content-.”
– Founder Lyndsey Linke